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ABSTRACT 
Inducing a Normal Phenotype in Breast Epithelial Cells Using a Three- 
Dimensional Basement Membrane Extract Culture System:  
A Study on the Reversion of Cancer 
by 
Ross H. Booth, Master of Science 
Utah State University, 2009 
Major Professor: Dr. Soonjo Kwon 
Department: Biological and Irrigation Engineering 
Experimentally, traditional developmental models and transgenic animals 
consistently underscore the importance of studying cell behavior in the correct tissue 
context. However, live animal experimentation is inherently complex, and systematic 
assessment of the effects of individual variables, such as cell shape and matrix compliance 
on cell behavior, is extremely difficult at best.  Two-dimensional monolayer culture of key 
individual cell types has provided abundant, fundamental information on cell response, but 
cannot be used to show the normal phenotype of breast epithelial cells.  Furthermore, their 
results often fail to translate into in vivo and clinical studies.  It has been previously 
established that normal human breast epithelial cells can form their original phenotype as 
seen in vivo when embedded in or layered on reconstituted basement membrane extract.  
This phenotype is characterized as a single or double layer of polarized cells in acinar form 
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with a lumen devoid of cells.  Most malignant cell lines cultured under the same conditions 
exhibit severe morphological deformities, including colony overgrowth, luminal filling 
(hyperplasia), and resistance to apoptosis. It was hypothesized that malignant breast cells 
can be reverted to a normal phenotype through the manipulation of two factors: control of 
the environment via extra-cellular matrix proteins, and control of cellular pathways via 
signaling inhibitors. It was observed that high levels of epidermal growth factor resulted in 
disrupted multi-acinar formations. Inhibition of the protein complex known as mammalian 
target of rapamycin is currently being investigated as a potential method for cancer 
treatment. Exposure of rapamycin, mammalian target of rapamycin’s primary inhibitor, led 
to decreased proliferation and increased caspase activity. Through the exposure to 
rapamycin in three-dimensional cultures, proliferation was reduced in malignant cells, 
while normal cells were not significantly affected. Unfixed fluorescent staining with 
ethidium bromide indicated the presence of luminal cell death.  Increased structural 
organization was observed by immunofluorescent staining of F-actin and β-catenin. 
Through RT-PCR analysis, increased expression of a number of genes related to polarity 
and structural organization was detected in malignant cells exposed to rapamycin. Further 
study will be required to better characterize the reversion effects of rapamycin and its 
derivatives. 
(74 pages) 
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PREFACE 
• Note that the term malignant is used frequently in this paper.  The term “malignant” 
is often used to describe tumors that have ceased to be benign and have become 
invasive. In this paper (and much of the cited literature) the term malignant is 
intended to refer to all cancer cells. 
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CHAPTER 1 
INTRODUCTION 
The history of cancer research, as young as it is, has gone through rapid changes in 
a short period of time. As new causes for cancer have been discovered throughout the 20th 
century - from the Rous Sarcoma Virus in 1910 to the first proto-oncogene in 1975 and the 
now hundreds of suspect carcinogens being rigorously investigated – the focus of cancer 
researchers has constantly been changing direction. As cancer ascends to become the 
world’s leading cause of death, the fierce debate over where researchers should focus their 
attention continues. While most traditional studies of cancer focus primarily on the 
signaling, chemistry, and genetics of individual cancer cells, a growing movement of 
researchers has been publishing work asserting that tissue microenvironmental influences 
should be held coequal. For many, adopting this perspective has required them to take a 
unique approach to cancer research, but history has shown that exploring new paths of 
inquiry can be productive to scientific progress. 
1.1 Achieving Physiological Accuracy in Cellular Models 
The case for the importance of cell-based in vitro models needs little persuasion. Before 
clinical studies can begin, the concept in question must be well established in laboratory 
studies. While animal models can be very useful, in vitro models are often preferred due to 
ethical, technical, and financial constraints. In addition, a greater amount of experimental 
control is allotted to the researcher using cell-based models. For this reason there has been 
a very high demand for effective cell-based models in cancer research [1]. 
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 However, for a cellular model to be useful, it must properly represent conditions 
found in vivo. One of the advantages of human cell-based models over animal studies is 
that the researcher can avoid complications from species-dependent concepts. There 
remains an advantage for animal models in that they address a higher level of complexity 
which existing cellular models do not have. This level of complexity must be addressed in 
cellular models to overcome this advantage. 
1.1.1 Adding an Extra Dimension 
Cytotoxic agents and tumor suppressors tested successfully on two-Dimensional 
(2D) plastic cultures often fail to translate successfully into in vivo research. This resistance 
to signaling factors is also sometimes present in three-dimensional (3D) culture systems 
[2]. This presents a real issue for 2D cultures, as they fail to address this resistance to drugs 
which is often present in actual tissues. 
Accurate cell differentiation and functionality often has 3D spatial requirements [3], 
and the polarized phenotype that epithelial cells possess in vivo is rarely observed in 2D 
cultures. Breast cancers are subdivided into at least 18 distinct subtypes [4], each with 
unique histological properties. These can be difficult to differentiate visually from 
appearance on a plastic monolayer, but these differences are better visually recognized 
when placed in 3D culture models (Figure 1). Even the differences between normal and 
cancer cells can be difficult to distinguish in 2D, while easily characterized when placed in 
3D cultures. 
 Figure 1: Normal Cells Cultured in 2D and 3D
The difference between morphologies
cultures adhere to the plastic surface and reach confluence, while the same cells cultured in 
3D will spread 3-dimensionally and limit their growth. (scale bars = 25 µm)
1.1.2 Experimental Control
There is an inverse correlation between model complexity and experimental 
control. Therefore, a balance must be found between maximizing model complexity and 
maintaining control over experimental design. To 
lumped into two classes: 
microenvironment has often been understated as excitement over the discovery of 
oncogenes has led researchers to focus their attention on genetic mutation as the cause of 
cancer and metastasis. However, data contradictory to the somatic mutation theory 
allowed new theories to be proposed. These theories suggest that research should be 
looking not only for intracellular targets, but 
and their microenvironment.
The microenvironment 
as the surrounding extra
 
 on Day 6 of Culture
 of cells cultured in 2D and 3D are clear. Monolayer 
 
simplify, controllable factors have been 
signal molecules and microenvironment. The importance of
also at the interactions between cancer cells 
 
includes the 3D arrangement of the cells themselves
-cellular matrix (ECM). The ECM is not merely a
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[5] has 
, as well 
 structural 
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scaffold, but directly affects a series of intracellular pathways which modify the expressed 
phenotype in a variety of ways [6]. A reciprocal interaction between tissue architecture and 
gene expression is strongly supported [7] and will be discussed in the following section. 
1.1.3 Mechanisms of Microenvironmental Impact on Phenotype 
Two broad hypotheses were proposed in a recent review article which effectively 
asserts the importance of the microenvironment in cancer development.  
First, that tumour cells with abnormal genomes should be capable of 
becoming phenotypically normal if their normal microenvironment can be restored, 
and, secondly (and conversely), that the destruction of tissue structure itself could 
be an oncogenic event, even in the absence of initial genetic mutation. [8]   
Indeed, bolder advocates of the 3D method suggest that tissues are constantly being 
bombarded with oncogenic factors, and that the proper maintenance of tissue architecture 
and polarity is a sole factor preventing oncogenesis [3, 9]. There are two general methods 
through which the ECM directs cell pathways. The first is directly through membrane-
bound receptors on the exterior cells, and the second is through other pathways which are 
indirectly dependent on morphology [10]. The mechanisms through which epithelial cells 
receive cues from the surrounding ECM have been studied extensively. The most well 
established mechanism is through membrane-bound integrins [11]. 
Cells in a dynamic human body are constantly undergoing physical forces. These 
forces include shear stress, compression and tension forces, and hydrostatic pressure. Cells 
have mechanisms for detecting these forces, and they can have a major effect on cellular 
pathology, including cancer. The loss of tensional homeostasis can increase cancer risks 
and compromise treatment [12, 13]. Culturing in 3D is associated with an increase in global 
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histone acetylation [14], which results in chromatin condensation and a decrease in cell 
proliferation. 
Matrix metallo-proteinases (MMPs) are ECM-degrading proteins which are often 
dispatched into the stroma [15]. Epithelial mesenchymal transition (EMT), a phenotypic 
alteration in which epithelial cells detach from their neighbors and the underlying basement 
membrane and become more motile and migratory, which has profound effects on tumor 
metastasis, is known to be induced by pathways including MMPs. However, this process 
has been shown to be limited by changes in cell shape [16]. Another recent study 
measuring the branching locations of metastasizing cells using micropatterning found that, 
remarkably, branch sites were located only on tubule corners [8], indicating a dependency 
on tissue architecture. 
1.1.4 The Functional Unit 
One primary difference between 3D and 2D culture models is the functional unit.  
Traditionally the functional unit was the individual cell, but in 3D cultures the functional 
unit is the entire structure the cells form [17]. As a result, a greater amount of criteria can 
be investigated on a single functional unit which couldn’t before, such as tissue polarity, 
cell-cell communication, multicellular structure, and localization of function. 
Identification of the functional unit is a first step in experimental design. In the case 
of breast cancer, the mammary acinus is the unit of interest, and is characterized by a 
spherical formation consisting of a single layer of epithelial cells surrounding an empty 
lumen. The purpose of the lumen in ducts is to carry milk proteins to the branching 
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locations and ultimately the nipple. The development of ducts from alveoli is led by a 
complex differentiation process which is still poorly understood [18]. The process of 
alveolar branching and the generation of ducts has been observed to be dependent upon 
communication with the ECM surroundings [19]. These cells go through differentiation 
many times through the life of the individual, including periods such as puberty and 
lactation.  Perhaps this is why the breast is so vulnerable to cancer. 
In most cell lines, the structure forms from a single cell over a period of 6-10 days 
(Figure 2) in 3D culture. The precise mechanisms are not well understood, but the cells 
begin to polarize, leading to survival of outer cells, and death of luminal cells. 
 
Figure 2: Formation of the Mammary Gland Acinus in vitro 
The functional unit for human breast epithelial cells is a spherical acinus consisting 
of an outer layer of cells and a lumen devoid of cells. In culture, polarization of the 
outer cells leads to apoptosis of un-polarized cells in the center [9]. 
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1.1.5 ECM and Basolateral Polarity 
A unique characteristic of epithelial cells is their ability to functionally polarize.  
The membrane-bound proteins and biochemical activity on each (basal and luminal) side 
are different in polarized cells. For example, in the breast acinus, the activity on the luminal 
side includes cues which incite apoptosis on interior cells, and the activity on the basal side 
includes interaction with the basement membrane. Myoepithelial cells, while normally 
present in vivo, are normally left out of these cultures. This is because their functional role 
in polarity appears to be maintenance of the basement membrane [20]. Luminal formation 
is still poorly understood, but is mostly likely caused by induced apoptosis of interior cells 
separated from the exterior layer. As this only happens in the presence of a polarized outer 
layer, a signal is likely being transmitted from the luminal edge of the exterior cells which 
is initiating terminal pathways [21]. 
As early as the 1970s, the importance of the basement membrane and basolateral 
polarity in structural development of healthy tissues was being discussed [22], and normal 
polarity was achieved using ECM-based gels in culture as early as 1992 [23]. Choice of 
ECM is not only important because it provides physical support and special freedom for 
acinar formation; it promotes cell polarity. However, basal cells are only responsive to the 
correct ECM recipe. While collagen is the most commonly found ECM protein in the body 
and is commonly used in tissue engineering, polarity has been found to be preserved best 
when using proteins which closely resemble the basement membrane [24]. The mixture 
derived commercially from the Engelbroth-Holm Swarm (EHS) tumor, better known as 
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reconstituted basement membrane extract (rBME), was found experimentally to be the best 
option and is still used today. 
 The primary component in rBME is laminin-I, which has been found to directly 
induce higher integrin activity and better adhesion in preadipocyte cells [25]. Laminin-I is 
also known to be have a strong role in early tissue organization of embryos in the womb 
[26]. Other components of rBME include procollagen IV, heparin sulfate proteoglycan, and 
entactin [27]. It is likely that all these basement membrane components play a role in 
directing an optimal phenotype, though these roles are still not well characterized. Still, 
laminin is believed to be the most important component [28]. 
1.2 Previous Studies 
 Table 1 lists several signal molecules which have been investigated using 3D 
culture models. In vivo, tumor cells lose some or all of their morphological organization in 
healthy tissue. Using 3D cultures as introduced in the previous section, cancer cells can be 
studied through morphological observation. In 2D, normal and malignant cells similarly 
form adherent monolayers, but when placed in 3D rBME, the difference becomes clear. 
Morphological disruptions are present in the malignant cultures just as they are in vivo. 
Through the manipulation of signal molecules, malignant cultures can be reverted back to a 
normal phenotype. This is commonly termed a reversion strategy. 
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Table 1: Previous Studies Using 3D Culture Models  
Manipulation of the phenotype of normal and malignant cells cultured in 3D can provide 
valuable insight into cell communication pathways, and potential causes and treatments of 
cancer. 
Pathway Description of Results 
Rap1 GTPase Found to be crucial in organizing acinar structure and inducing lumen 
formation. Inhibition of Rap1 led to phenotypic reversion. [29]   
β1-integrin Inhibition of β1-integrin with blocking antibodies led to significan loss of 
cancer cell proliferation, increased apoptosis. Re-organized cytoskeletons. 
Non-malignant cells were resistant to any change. [30-32]    
cAMP cAMP analogues increased malignant cells’ sensitivity to AluI digestion, 
and to revert the structures to normal polarity. [33]   
PI3K Kinase Inhibition of PI3K reverted tissue polarity and decreased proliferation. Led 
to down-modulation of β1-integrin and EGFR, and up-regulation of 
PTEN. [34] 
EGFR, 
MAPK 
Reversion and reduced malignant behavior, decreased proliferation and 
increased polarity. [31] 
PI3K Kinase Normal cells with mutations to PI3K exhibit severe morphological 
deformities. [35]  
ErbB2 ErbB2, but not ErbB1, reinititates proliferation and induces luminal 
repopulation in epithelial acini. [36] 
Insulin-like 
growth factor 
Type I insulin-like growth factor receptor overexpression led to large 
misshapen structures with filled lumena and disrupted polarization. [37] 
It’s been shown using 3D rBME cultures that regardless of growth status, in both 
malignant and nonmalignant mammary epithelial cells, the presence of the basement 
membrane provides protection from apoptosis. This suggests that integrin-induced polarity 
drives tumor-cell resistance to apoptotic agents via NFkB [38]. More specifically, the 
formation of polarized acini are dependent on the activity of α6 and β1 surface integrins, in 
combination with the presence of laminin-I [39]. Researchers have found a reciprocal 
cross-modulation between β1-integrin and EGFR which was not present in 2D cultures. 
This cross-modulation was attributed to being dependent on the presence of the basement 
membrane [40]. Experimentation with 3D cultures has led to the conclusion that apoptosis 
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must be restrained through resistance pathways for the lumen to become populated [41]. It 
was also found that luminal formation in rBME cultures required carcinoembryonic 
antigen—related cell adhesion molecule (CEACAM), to be present a high levels. This 
suggests that the morphogenic program integrates both cell-cell and cell-ECM signaling to 
produce the lumen [42]. The importance of MMP activity on branching morphogenesis was 
successfully demonstrated using 3D rBME cultures [43]. Similar in vitro models have been 
developed for other cell types, including skin, prostate, muscle, colon, bile duct, esophagus, 
adipocytes, fibroblasts, and embryonic stem cells [4]. Some of them are being used to study 
the same groups of pathways as well. For example, the disruption of the PI3K pathway has 
been found to have a similarly profound impact on the morphogenesis of epithelial acini in 
prostate cancer [44]. 
1.3 Mammalian Target of Rapamycin 
 To attempt to induce a normal phenotype for malignant cells, it was desired to 
select a compound with a great foundation of literary support to justify its selection, but 
also to design an original experiment. Rapamycin is the primary inhibitor for the 
mammalian target of rapamycin (mTOR) pathway. In a study using a non-cancerous breast 
epithelial cell line cultured in 3D with rBME, activation of the Akt kinase caused the cells 
to form morphologically disrupted structures with amplified proliferation. Inhibition with 
rapamycin completely reversed this malignant behavior [45]. Though rapamycin and other 
mTOR inhibitors are being investigated as cancer drugs, the effectiveness of mTOR 
 
inhibition as a reversion strategy for 
be unexplored. These are 
1.3.1 History of Use 
Rapamycin was identified in 
found to be a potent suppressor of the immune system.
use under the drug name Sirolimus as an immunosuppressive drug. Its immunosuppressive 
mechanism is derived from its inhibitory effect on the progression of T
phase into S phase [46].
proven effective in improvement of liver function in rat models, even in low doses
structure is displayed in Figure 
because of formulation and stability concerns in producing a
Figure 3
Figure was released to Wikipedia.org as public domain.
 
breast cancer cell lines using rBME cultures
the reasons rapamycin was chosen for this study.
the mid-1970s as a potent antifungal agent
 It was FDA approved in 1999 for 
 Rapamycin is also being used to treat liver cirrhosis, and has 
3. Its development as a cancer therapy has been far slower 
 parenteral formulation
 
: Structure of Rapamycin (Sirolimus) 
 
11 
 appears to 
 
 and was 
-cells from G1-
 [47]. Its 
 [48]. 
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In a study utilizing 3D rBME-embedded culture models, Akt activation elicited 
large, misshapen structures with enhanced proliferation and increased cell size. However, 
mTOR inhibition by rapamycin was shown to completely cancel these effects [49]. This 
study was the primary source for the selection of rapamycin as an exposure factor for 
reversion. 
1.3.2 The Akt – mTOR Tango and Other Cancer Pathways 
The serine/threonine kinase Akt (also known as PKB) is known to have at least 
three major impacts on cancer progression: proliferation, survival, and cell growth. For this 
reason, it is one of the most intensively studied pathways in breast cancer research. Down-
regulation of Akt has been seen to inhibit anchorage-independent cell growth and induce 
apoptosis in various cancer cell lines [50]. Akt inactivates the downstream protein BAD, 
which normally promotes cell apoptosis in non-polarized cells [51]. PTEN, a tumor 
suppressor gene whose activity inhibits Akt phosphorylation, can be inhibited by mTOR. 
Therefore mTOR inhibition leads to PTEN upregulation, and hence Akt suppression [52]. 
The complex pathway web which includes mTOR, Akt, PI3K, and PTEN has been 
found to have various functions, including cell progression, angiogenesis, and resistance to 
apoptosis [53, 54]. Currently, rapamycin-chemotherapy pre-clinical combination studies 
are being conducted on mouse models to investigate rapamycin’s effect on PI3K-induced 
cancers [55]. In prostate cells, doxorubicin resistance was reversed by rapamycin [56]. 
Rapamycin has been shown to reverse chemoresistance in lymphomas expressing Akt [57]. 
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The effects of statins on Akt signaling was found only to be effective when used in 
combination with rapamycin [58]. 
The effects of mTOR on cancer pathways are not limited to Akt.  Rapamycin 
exposure on mice was found to increase the levels of nitric oxide synthase in inflammatory 
responses. These effects appeared to be caused by mechanisms other than Akt [59], 
suggesting that mTOR has effects on other signal cascades. Rapamycin-induced inhibition 
of mTOR has been shown to inhibit MMP-7 production in mouse models [60], and MMP-9 
has also been shown to be reduced by rapamycin exposure [61]. Increased MMP 
production is known to lead to breakdown of the ECM in many cases. In glioma cell lines, 
MMP-1, MMP-2, and MMP-9 was downregulated after treatment with rapamycin [62].  
Inhibition of mTOR was found to have no effect on sensitivity to radiation therapy 
on glioblastoma cells when conducted in a monolayer, but was greatly increased when 
applied in vivo [63]. This further illustrates the importance of 3D cultures, while building 
the case for rapamycin as a cancer drug. Rapamycin exposure has also been shown to 
suppress tumor growth by anti-angiogenic suppression of vascular endothelial growth 
factor (VEGF) production [64]. In acute lymphoblast leukemia cells, rapamycin induced 
apoptosis and increased doxorubicin-induced apoptosis in many samples analyzed [65]. 
Cell proliferation tests demonstrated that rapamycin enhanced cell sensitivity to endocrine 
therapy in breast cancer cells [66]. 
 Two distinct protein complexes are known to bind to mTOR: Raptor and Rictor.  
The mTOR-Raptor complex is exclusively downstream from Akt, while the mTOR-Rictor 
complex has a feedback mechanism by which it enhances Akt activity through PI3K and 
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PTEN. In effect, mTOR acts both downstream and upstream from Akt [67] in the signaling 
cascade. This is one very interesting aspect of the mTOR pathway, in that inhibiting it 
undoubtedly has multiple effects on cellular pathways. 
1.4 Hypothesis & Aims 
 From the preceding literature review, the following hypothesis was formulated: 
Malignant cells, cultured in 3D rBME and exposed to rapamycin, can be forced to revert to 
a normal phenotype. Phenotypic reversion criteria include: 
1. Decreased proliferation – smaller, growth-arrested colonies 
2. Structural organization – spherical structures with increased multi-cellular 
organization and an ordered cytoskeleton 
3. Polarization – increased interaction with the basement membrane and luminal 
formation in the center of the colonies 
To conduct this experiment, two primary aims were developed: 
1. Establishment of normal phenotype of normal cells cultured in 3D rBME as a 
positive control through optimization of culture conditions 
2. Observing the effects of rapamycin on the phenotype of malignant cells cultured in 
3D rBME.with comparisons to normal cells 
  
  There are two primary methods 
first, embedded, involves fully embedding cells in a thick layer of gel, while the second, 
on-top, involves laying cells on
the media at low concent
top method has two advantages
colonies into approximately the same 
significantly easier. For this study, only 3D on
descriptions of methods used, see 
Figure 
Individual cells are initially seeded on
media containing 2-10% rBME v/v. Gel slightly thickens over time as more rBME is added 
every 2 days, and colonies grow into acini.
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-top a thin layer of gel while slowly adding additional gel in 
rations. Both methods allow 3D structure formation, but the on
. First, it uses significantly less materials. S
horizontal plane. This makes image analysis 
-top was used (Figure 4). For more detailed 
Appendix A. 
4: 3D on-top Method of Cell Culture 
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2.1 Cell Culture  
Malignant breast epithelial cells (BT-483, MDA-MB-468) and normal breast 
epithelial cells (184-B5) were purchased from ATCC (VA). For monolayer culture, BT-
483 was cultured using RPMI-1640 (Sigma-Aldrich, MO) with 20% fetal bovine serum 
(FBS) (Thermo Fisher Scientific, UT) and 0.01 mg/mL bovine insulin, MDA-MB-468 was 
cultured using Leibovitz’s L-15 Media (Sigma-Aldrich) with 10% FBS in air with no 
added CO2, and 184-B5 was cultured using MEGM (Lonza, Switzerland) with 1 ng/mL of 
cholera toxin and without gentamycin-amphotericin-B.  
To achieve luminal morphology, cells were cultured using 3D on-top assays as 
previously described [68, 69]. The cultrex 3D culture matrix (Trevigen, MD) rBME 
product was chosen because it was specifically formulated for breast epithelial cell cultures 
and is modified to contain reduced growth factors and is phenol red free. Assay media was 
modified to contain 2-10% BME, with 2% FBS for malignant cells and with or without 
EGF (Epidermal Growth Factor) supplements for normal cells. All media was 
supplemented with 1% Penicillin/Streptomycin (Invitrogen, CA) and 0.1% Fungizone 
(Hyclone, UT). Cell cultures were seeded at 0.25x105 (184-B5), 0.22x105 (BT-483), and 
0.18x105 (MDA-MB-468) cells/cm2. Assay media was changed every two days subsequent 
to seeding. Rapamycin (Sigma-Aldrich, MO) was reconstituted in DMSO and stored at -
20°C at a stock concentration of 1 µM. 
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2.2 Morphological Observation 
 Morphology was observed using a TE2000-S Eclipse Microscope (Nikon, Japan) or 
a TS100 Eclipse Microscope (Nikon, Japan). All images were taken with a Digitial Sight 
DSQi1Mc Camera (Nikon, Japan). Fluorescence images were detected with an Intensilight 
C-HGFI lamp (Nikon, Japan). For the detection of non-viable (or apoptotic) cells, non-
fixed cultures were incubated for 15-30 minutes with 1 µM ethidium bromide or 500 nM 
propidium iodide and observed for fluorescence. Cell colonies were extracted using PBS-
EDTA solution, fixed using 4% paraformaldehyde, and blocked with 10% goat serum and 
1% goat F(ab’) IgG (Sigma-Aldrich, MO).  Monoclonal anti-actin (1A4) and monoclonal 
anti-β-catenin (15B8) were obtained from Sigma-Aldrich (St. Louis, MO) for use as 
primary antibodies. Secondary antibody for FITC-conjugated goat anti-mouse was obtained 
from Santa Cruz Biotechnology (CA). Image analysis was conducted using NIS-Elements 
v3.0 (Nikon).  Areas of cell colonies (in the x-y plane) in all images were analyzed for the 
calculation of mean areas under different conditions. 
2.3 Caspase 3/7 Assay 
 Monolayers of BT-483 and 184-B5 cells were prepared in a 96-well plate to 
analyze the effects of RAP on caspase activity.  Caspase activity was measured at 24 and 
48 hours following exposure to RAP at 0, 5, and 20 nM. Exactly 100 µL of Casapase-Glo 
3/7 Reagent (Promega, WI) was added to each sample, including 2 blank wells containing 
100 µL of growth media and incubated for 2 hours.  Luminescence was then measured 
using a Synergy 4 Plate Reader (Biotek, VT). 
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2.4 Cell Viability Assay 
CellTiter-Blue Cell Viability Assay reagent was obtained from Promega (WI). 
MDA-MB-468 and 184-B5 cells were seeded in 96-well plates and, beginning on day two, 
were treated continuously with 0 nM and 20 nM RAP.  On day three and day seven, cell 
viability assays were conducted and measured for fluorescence. 
2.5 Real-Time RT-PCR Arrays 
Human extracellular matrix and adhesion molecule-based real time reverse 
transcriptase polymerase chain reaction (RT-PCR) SuperArrays were obtained from 
SABiosciences (MD). MDA-MB-468 cells cultured in 3D on BME gels were treated with 
0 nM and 20 nM RAP for six days. Colonies were extracted using PBS-EDTA, mRNA was 
extracted using RNeasy RNA isolation kit (QIAGEN, CA), and cDNA synthesis was 
conducted using the Reverse Transcriptase First Strand Kit (SABiosciences, MD). Real 
time PCR arrays were run using a Bio-Rad Opticon 2 thermocycler system (MJ Research, 
Canada) and analyzed using the Opticon 2 software provided. Ct values were acquired 
graphically. 
2.6 Statistical Analysis  
With the SYSTAT 12 software, statistical analyses on all quantitative data were 
carried out using one-way and two-way ANOVA (analyses of variance) to verify 
statistical significance (p < 0.05). 
 3.1 Optimization of Culture Conditions
Using the 3D on-
MEGM-based assay medium
supplement provided with the Media kit.
disrupted structures with no apparent limitations to growth.
reduced media resulted in 
in shape. This effect is demon
a maximum size by day 6
EGF-induced morphological distortion. 
Figure 5. Effects of EGF on 3D Morphology of Normal Cells
184B5 breast epithelial cells cultured on
reduced assay media induce
with maximum size by day 5 of culture. 
increased proliferation and disrupted morphology. (Scale bars = 25 µm)
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 Culturing the cells in EGF
the formation of significantly smaller structures with uniformity 
strated in Figure 5.  EGF-reduced cultures appeared
 of culture. Exposure to 20 nM rapamycin had no visible effect on 
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Figure 6. Effects of Reducing EGF on Average Colony Size for Normal Cells 
Average cell colony areas were measured from 184B5 breast epithelial cells cultured on-
top BME gels with and without EGF on day 7 of culture. EGF-reduced colonies showed a 
significantly lower average area than the EGF-enhanced colonies. (* Significantly lower 
than control, Error bars + st. dev,  p < 0.05) 
 
 
Image analysis of average area of normal cells with and without EGF showed a 
significantly lower area for EGF-reduced colonies at day 7 (Figure 6). This proves 
quantitatively that EGF causes over-proliferation and prevents proper formation of the 
normal phenotype. 
Malignant cells cultured using the 3D on-top method grew into large, 
morphologically disrupted structures. Unlike EGF reduction, FBS reduction did not lead to 
a change in morphology. Subsequently, 2% FBS was used in all experiments. 
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3.2 Effects of Rapamycin Exposure 
3.2.1 Caspase 3/7 Activity 
 Figures 7 and 8 show the effects of rapamycin exposure on caspase activity in 
normal (184-B5) and malignant (BT-483) breast epithelial cells. For normal cells, the only 
condition which showed significant deviation fom the control was 20 nM rapamycin for 48 
hours of exposure. For malignant cells, 20 nM of exposure showed a significantly higher 
effect on caspase activity than 5 nM, but only at 48 hours of exposure. Caspase 3 and 
caspase 7 are established markers for programmed cell death. Programmed cell death is 
required for the formation of the luminal space in 3D cultures, so this data provides 
evidence that rapamycin can have an effect on polarity. For raw data, see Appendix B. 
 
Figure 7: Caspase 3/7 Response in Normal Cells From Rapamycin Exposure 
Effect on caspase activity of normal (184-B5) breast epithelial cell monolayers at 24 and 48 
hours of exposure to 0, 5, and 20 nM rapamycin. (n=2, * significantly higher than control, 
+ significantly higher than 5 nM, error bars + st. dev., p <0.05) 
+
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Figure 8: Caspase 3/7 Response in Malignant Cells From Rapamycin Exposure 
Effect on caspase activity of malignant (BT-483) breast epithelial cell monolayers at 24 and 
48 hours of exposure to 0, 5, and 20 nM rapamycin. (n=2, * significantly higher than 
control, + significantly higher than 5 nM, error bars + st. dev., p <0.05) 
3.2.2 Cell Viability Assay 
 Figure 9 shows the effects of 20 nM rapamycin on the total level of cell viability in 
monolayer cultures of both normal (184-B5) and malignant (MDA-MB-468) cells after 2 
and 6 days of continuous exposure (and one day untreated). Both cell lines (MDA-MB-468 
& 184-B5) showed a significant reduction in cell proliferation with a significantly higher 
reduction seen on day 7 than on day 3. This shows that Rapamycin has either a cytotoxic 
effect, or that it leads to downstream regulation of the cell cycle. The caspase data 
previously shown provides evidence that the latter is true. All conditions were conducted in 
triplicates.  Error bars show the standard deviation among the three samples, and in all 
cases there is no overlap between the error bars of the control and treatment samples.  This 
data shows a significant change in viable cells in each of the treated samples conditions 
*
*
+
*
0.0E+00
5.0E+03
1.0E+04
1.5E+04
2.0E+04
2.5E+04
3.0E+04
24 hrs 48 hrs
RLUs
Exposure Time
0 nM CTRL
5 nM RAP
20 nM RAP
23 
 
 
(p<0.05). This is quantitative supporting evidence that rapamycin limits cell proliferation, 
at an increasing margin over time. For raw data, see Appendix B. 
 
 
Figure 9: Proliferation of Normal and Malignant Cells  
at 2 & 6 Days of Rapamycin Exposure 
Monolayer cultures of normal (184-B5) and malignant (MDA-MB-468) cells were exposed 
for 2 & 6 days to 20 nM rapamycin, and analyzed for total cell viability. Levels of cell 
viability were significantly lower under all conditions for rapamycin-treated cultures, by an 
increasing margin over time. (n=3, * significantly lower than control, p < 0.05) 
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3.2.3 Morphological Observation
Exposure with 20 nM r
cell colonies, typically reaching their maximum size by day 
were comparable in size and shape to 
reduction of average cell colony area (
MDA-MB-468). 
Figure 10
Rapamycin was exposed to malignant (BT
0 and 20 nM concentrations, and compared to normal (184
bottom, compared in colony shape and size to rapamycin
Malignant cells, top, exhbited severe morphological disruption when cultured without 
treatment. (Scale bars = 25 
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6 (Figure 10
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Figure 11. Effects of Rapamycin Exposure on Average Cell Colony Size of  
Malignant Cells on Day 7 of 3D Culture 
Effects of rapamycin exposure on average cell colony size: Average cell colony areas were 
measured from malignant (BT-483 & MDA-MB-468) cells continuously treated with 0 and 
20 nM rapamycin Average cell colony areas (xy plane) were measured from BT-483 and 
MDA-MB-468 malignant cells treated with 0 and 20 nM RAP on day 7 of 3D rBME 
culture. No significant difference was found between the two cell lines, but rapamycin 
treatment significantly reduced cell colony size. (Error bars + st. dev, * significantly lower 
than control, p < 0.05). 
 
 
 
 Labelling of apoptotic cells was done using ethidium bromide and propidium iodide 
to stain un-fixed 3D cultures of normal and malignant cells (Figure 12) at day 8 of culture. 
An inner subset of cells undergoing luminal cell death (apoptosis) was observed in normal 
cell colonies, as well as malignant cell colonies treated continuously with rapamycin. This 
indicates the presence of lumen formation, and provides evidence that rapamycin treatment 
induced the cells to exhibit polarity. 
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 Figure 12. Selective 
Top: Staining of day 8 3D cultures of 
propidium idodie resulted in detection of cell death in the center of cell colonies. 
Bottom & Middle: Similar occurences of centrally
both cancer cell lines (BT
rapamycin. (Scale bars = 25 µm)
 Structural organization was observed using anti
immunofluorescent stains. The results are pictured in 
FITC secondary antibod
malignant cells and normal cells exhibited primarily spherical mu
untreated malignant cells show
exhibited cells arranged around the center
cells cultured in rBME. 
 
Staining of Non-Viable Cells Indicates the 
Presence of Luminal Apoptosis 
normal (184-B5) cells with ethidium bromide or 
-localized apoptosis were detected in 
-483 & MDA-MB-468) when treated continuously with 20 nM 
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-β-catenin 
 stained with 
).  Reverted 
 Figure 13. Immunofluor
Malignant Cells at Day 7 of 
Malignant (BT-483) cell colonies from day 7 of culture, after continuous treatment of 20 
nM rapamycin from day 2, exhibit multi
normal (184-B5) cells.  
Top: Anti-actin (green) counterstained with DAPI (blu
Bottom: Anti-β-batenin (green) counterstained with DAPI (blue). (Scale bars = 25 µm)
3.2.4 RT-PCR Arrays 
 Two PCR array plates containing genes related to 
molecules were run together with cDNA derived from mRNA 
cells grown in rBME. One sample, as a control, was untreated. The oth
exposed to 20 nM rapamycin for 
included six wells for positive controls and 
check. The genomic DNA con
was no genomic DNA contamination. 
below 1, as was the difference between the average controls for the t
 
escent Staining of Normal Cells and Rapamycin Treated 
3D Culture 
-cellular organization similar to day 7 cultures of 
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four days after two days untreated. 
one well for a genomic DNA contamination 
tamination wells were both >35, which indicates that there 
The standard deviation for all controls were well 
27 
 
 
r and adhesion 
-132 
er sample was 
The PCR arrays 
wo plates. The 
28 
 
 
difference between the reverse transcription control (RTC) and the positive PCR control 
(PPC) was < 5, which designates the presence of successful PCR reactions. From these 
calculations, it was concluded that the data is acceptable for analysis. See appendix for raw 
data and quality control analysis. 
 Ct values were cutoff at > 35 as undetected. Fold change of each gene was 
calculated using the DDCT (∆∆Ct) and classified according to gene category (Table 2). 
Data was cutoff as significant at a fold change of < 0.2 or > 5.0. See appendix for 
additional tables containing genes inside the cutoff range, and genes for which no fold 
change could be calculated due to a Ct value of > 35.  
 Twenty-five genes related to ECM & adhesion molecules showed a significant (at 
least 5-fold) increase in expression, while no genes showed a significant (less than 0.2) 
decrease in expression. Gene groups including basement membrane constituents and cell-
matrix adhesion molecules support the presence of increased basolateral polarity in 3D 
cultured malignant cells treated with 20 nM rapamycin. Gene groups including cell-cell 
adhesion molecules, trans-membrane molecules, and other adhesion molecules such as 
catenin support the presence of increased structural organization in 3D cultured malignant 
cells treated with 20 nM rapamycin.  
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Table 2. Rapamycin’s Effects on Gene Expression of Human  
Extracellular Matrix and Adhesion Molecules 
Fold change was calculated using the DDCT method, with GADPH as the normalizing 
gene. See Appendix B for complete data. 
 
Gene 
Category Symbol Description 
Fold 
Change 
Basement 
Membrane 
Constituents 
LAMA2 Laminin, alpha 2 13.77 
LAMA3 Laminin, alpha 3 19.05 
LAMB3 Laminin, beta 3 12.57 
SPARC Secreted protein, acidic, cysteine-rich 13.64 
Cell-Cell 
Adhesion 
CDH1 Cadherin 1, type 1, E-cadherin (epithelial) 6.40 
CTNND1 Catenin (cadherin-associated protein), delta 1 7.13 
Cell-Matrix 
Adhesion 
CD44 CD44 molecule (Indian blood group) 6.95 
ITGA2 Integrin, alpha 2 9.84 
ITGA6 Integrin, alpha 6 5.26 
ITGAV Integrin, alpha V 8.99 
ITGB1 Integrin, beta 1 14.30 
ITGB2 Integrin, beta 2 9.27 
ITGB5 Integrin, beta 5 5.48 
SGCE Sarcoglycan, epsilon 5.25 
Collagens & 
ECM 
Structural 
Constituents 
COL1A1 Collagen, type I, alpha 1 5.79 
COL4A2 Collagen, type IV, alpha 2 9.77 
FN1 Fibronectin 1 16.51 
ECM 
Protease 
Inhibitors 
THBS1 Thrombospondin 1 16.02 
Other 
Adhesion 
Molecules 
COL12A
1 Collagen, type XII, alpha 1 17.50 
CTNNA1 Catenin (cadherin-associated protein), alpha 1 7.82 
CTNNB1 Catenin (cadherin-associated protein), beta 1 11.40 
LAMC1 Laminin, gamma 1 (formerly LAMB2) 6.36 
Other ECM 
Molecules 
TGFBI Transforming growth factor, beta-induced, 68kDa 10.04 
VCAN Versican 17.70 
Trans-
membrane 
Molecules 
ITGA4 Integrin, alpha 4 5.87 
 
 As shown in Figure 14, 
through elimination of EGF in normal cells, and through exposure to rapamycin in 
malignant cells. To reach this conclusion, we applied the results to three 
established in the introduction 
Figure 1
In normal cells, normal phenotyp
media, leading to limited proliferation, ma
Rapamycin limited proliferation of malignant cells and induce
PCR analysis showed an increase in gene expression of many molecules important to 
polarity and structural organization, including basement membrane components, cell
matrix adhesion molecules,
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DISCUSSION 
normal phenotype was achieved in 3D rBME cultures 
– structural organization, limited proliferation, and polarity.
4. Summary of Experimental Results 
e was achieved by removing EGF additive from the assay 
ximum cell colony size, and lumi
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Increased multi-cellular organization was observed in the anti-actin and anti-β-
catenin immunostaining images. The change in shape of the colonies from amorphous to 
round is the strongest evidence towards satisfying this criterion. An increase in structural 
organization was also supported by an increase in expression of genes related to cell-cell 
adhesion molecules and ECM structural constituents. 
Limitations on proliferation were observed through morphological observation as 
well, and were confirmed by the significant change in the average areas measured in 3D 
cell cultures treated with rapamycin. The cell viability assay data also provided evidence of 
a decrease in proliferation due to rapamycin.  
Evidence of increased polarity due to rapamycin exposure was provided by the 
images of apoptotic cells located in the center of several cell colonies, indicating the 
formation of a lumen. The observed increase in caspase activity provides evidence that 
rapamycin affects the cell cycle and forces programmed cell death. Finally, an observed 
increase in expression of genes related to basement membrane constituents and cell-matrix 
adhesion molecules provides additional evidence that polarization is taking place. 
Both qualitative and quantitative data was gathered to support all three criteria. 
Note that, in some previous studies, reversion has been concluded though only one or two 
of these criteria were satisfied [1, 9, 30, 31]. Therefore, a conclusion can be made that 
Rapamycin exposure, in combination with rBME surroundings and serum-reduced media, 
can revert malignant cells to show a normal phenotype in 3D cultures. 
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4.1 Drawbacks to the Study 
While the caspase and cell viability assays provided valuable insight into the effects 
of rapamycin exposure, this study would have benefited from similar data derived from 3D 
cultures. Both assays were attempted on 3D cultures, but failed to yield results with 
significant difference from the controls. The ECM gel may have been autofluorescing / 
autoluminescing. It is also possible that the assay reagents were either being absorbed by 
(or failing to penetrate) the ECM, or were reacting with the ECM. Assays which could be 
conducted on cells extracted from the ECM would likely have been much more effective. 
The study would also have benefited from immunostaining images with observed 
localization of function. Actin and β-catenin were not specifically localized, but present all 
throughout the colonies. Antibodies for molecules related to polarity, such as α6-integrin, 
would likely have been observed around the periphery of the colonies. Such localization 
would likely have only been possible with confocal microscopy. 
Furthermore, more replicates of the RT-PCR arrays would have statistically 
strengthened the gene expression data. However, great confidence is placed in 
commercially distributed PCR arrays, and researchers often publish data from a single set 
of PCR arrays if they come from a trusted manufacturer.  
Another drawback to this study is derived from the variability between different 
cell lines, which include morphological properties and nutrition requirements. A previous 
study classified malignant cell lines into four main classifications by morphology, which 
differ significantly in genotype [3]. The two cell lines used in this study had “mass” and 
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“grape-like” morphologies, but we cannot be certain whether rapamycin exposure would be 
effective on the other morphology types, “round” and “stellate”. 
When initially culturing normal (184-B5) cells, growth-arrested spherical acini 
were not observed. Decreasing the amount of growth factors in the media by removing the 
EGF supplement prevented this. Likely, the presence of such a high level of growth factors 
led to an override of pathways which limit proliferation and lead to increased cellular 
cooperation and structural organization. In addition to growth factors, these cultures are 
very sensitive to humidity, and dry out much easier than 2D cultures do.  
While this culture system has increased complexity when compared to plastic-
bound monolayers, it is still profoundly simple when compared to real breast tissue. Only 
one cell type, epithelial, is represented in this model, while real breast tissue contains many 
other cell types, including myoepithelial cells, fibroblasts, and adipose (fat) tissue. Co-
cultures of adipocyte/epithelial cells have been attempted [70]. There are many challenges 
in attempting such heterotypic cell cultures. Accounting for the different metabolic and 
nutritional requirements would be a difficult task indeed, and would require much 
experimentation to optimize. Another difficulty is that in actual tissue, cell types are 
separated from each other, such as epithelial cells from stromal cells by a basement 
membrane, but in co-cultures the cell types would be co-mingled. Finally, co-cultures 
containing normal and malignant cells together would need methods to control the ratios of 
cells, as they may grow at different rates [4]. 
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4.2 Future Direction 
Rapamycin has shown evidence of phenotypic reversion, but it is not the only 
mTOR inhibitor. Rapamycin is actually a poor parenteral drug, due to its poor water 
solubility and limited stability. Three analogues have been developed with improved 
pharmaceutical properties: CCI-799 (tensirolimus), RAD-001 (everolimus) and AP-23573 
(deforolimus, ARIAD). All three are more effective orally and are currently under drug 
trials [71, 72]. These derivatives should also be investigated for their effectiveness as 
reversion factors [52]. 
In addition, it would to be interesting to observe the effects of combining 
rapamycin with other signal molecules to see their combined or synergistic effects on 
reversion of breast cancer cells [73]. Such combination strategies for reversion have been 
done many times before [9]. Rapamycin’s synergistic effects with paclitaxel, carboplatin, 
and vinorelbine have been observed in a few breast cancer lines in vitro [53]. Mullerian 
inhibiting substance (MIS) has also been tested with rapamycin as a dual strategy for 
fighting ovarian cancer. Additive effects on MIS’s protein targets were observed [74] and 
assumed to be synergistic. The additive effects of combined exposure with doxorubicin and 
gemcitabine synergistically enhanced chemotherapy-induced cytotoxicity in breast cancer 
cells [75]. These studies suggest that doxorubicin, paclitaxel, carboplatin, vinorelbine, 
gemcitabine, and MIS would be valuable candidates for such a combination strategy. 
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Three-dimensional cultures could be used to observe the mechanical properties of 
normal and malignant breast cells. Such studies are currently being conducted [12, 76], and 
can have far-reaching new insights on the development of tumors, including potential new 
methods of treatment. If oncogenic behavior can be induced by applying external 
mechanical forces, it would give valuable insight into the importance of tissue 
microenvironment on tumor progression [8]. 
 Surgeons attempting breast-conservation therapy (BCT) for breast cancer patients 
would benefit greatly from an effective device for the detection of cancerous tissue in 
margins of extracted tumors, and the frequency of remission cases would be drastically cut. 
Ultrasound detection provides a promising option: it is relatively cheap and noninvasive 
[77]. Currently, mathematical models exist which attempt to explain patterns of cell 
configurations utilizing the single cell as the basic unit [78]. Testing indicates that as few as 
300 malignant cells in a tissue sample can be detected [79]. The model takes advantage of 
the fact that malignant cells have significantly larger nuclei than normal cells. A distinct 
correlation between the size of the nuclei and integrated backscatter coefficient values has 
been found through experimentation. In addition, apoptotic cells affect ultrasound readings 
[80]. This is likely due to the destructive interference resulting from greater randomization 
of cell nuclei [81]. 
 Three-dimensional co-cultures of normal and malignant cells should be developed 
for testing these ultrasound models. However, there are challenges involved. First, a 
uniformly distributed numerical model may not translate properly into a tissue sample or a 
cell-based model. In actual tissue, and in these cultures, there is little uniformity, due to the 
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complex architecture these cells arrange. Numerical models being proposed include both 
ordered lattices and randomized microstructures [82] to address this issue, but exactly how 
these numerical models will fare when applied to gel models will depend on several 
conditions. It should first be confirmed that the normal cells being used in the co-culture 
have significantly smaller nuclei than the malignant cells. If accurate measurement shows 
that the immortalized cell line used in this study also possesses enlarged nuclei, it may be 
better to acquire primary cells for use in co-culture. The second issue is whether the cell 
ratio can be easily controlled in a co-culture. It is already established from this study that 
cultures of one cell type can be controlled through modification of growth factors and other 
additives in the media, and through growth inhibitors such as rapamycin. However, the 
control of one cell type may lead to negative side effects on the other cell type, especially 
when the cell lines use different media. A promising side effect which was noticed during 
this study was that normal cells appeared unaffected by rapamycin when in 3D culture. 
This suggests that rapamycin may be a useful control factor for co-cultures. 
4.3 Conclusion 
 In this study, the effects of rapamycin exposure on the phenotypic reversion of 
malignant breast epithelial cell lines were investigated using a 3D rBME culture system. 
Microscopic observation of malignant 3D cell cultures treated with rapamycin showed 
greater similarities in morphology to normal cell cultures than in untreated malignant 
cultures. Comparison of the average horizontal areas of untreated and rapamycin-treated 
malignant cell colonies confirmed that rapamycin-treated malignant cell colonies are 
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significantly smaller in size. Increased structural organization was observed by 
immunofluorescent staining of anti-actin and anti-β-Catenin. On day 8 of 3D rBME 
cultures, rapamycin-treated malignant cells stained with ethidium bromide showed similar 
occurrences of luminal cell death to that observed in normal cultures, indicating re-
polarization of the epithelial cell layer. Supporting data from monolayer cultures indicated 
that levels of caspase activity was increased in the presence of rapamycin, and that 
proliferation over time was decreased. Gene expression analysis of rapamycin-treated 
malignant cells from 3D culture indicated an increase in the expression of several ECM or 
adhesion molecules important to polarity and structural organization. This collection of 
data supports our hypothesis that RAP exposure can revert malignant breast epithelial cells 
to a normal phenotype. 
Our study has provided data supporting the value of mTOR inhibition as a potential 
anti-tumor strategy. To provide further insight into mTOR inhibition, two further directions 
of research should be taken: additional studies on the effects of other mTOR inhibitors on 
phenotypic reversion, and combination studies to investigate the synergistic or combined 
effects of mTOR inhibition with other cancer targets. 
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APPENDIX A 
LABORATORY PROTOCOLS 
MAINTENANCE OF BREAST CANCER CELL LINES 
I recommend adding 10 mL of Pen-Strep & 1 mL of Fungizone to every 500 mL of Media 
 
CRL-8799 (or 184B5) 
• Non-cancer epithelial cell line, 21-year-old female 
• Cells reach confluence in 3-5 days, growth spreads very rapidly 
• Media: Use Mammary Epithelial Growth Medium (MEGM) from Clonetics. 
o Comes in a kit with MEBM & a series of supplements.   
o Do not add gentamycin-amphotericin B for CRL-8799 cells. 
o Save ¼ of the media, and exclude the EGF additive.   
 This media is to be used for 3D assays. 
o Also supplement all media with 1 ng/ml cholera toxin. 
o Serum Free 
• Cytoprotectant media contains 10% FBS & 5% DMSO. 
• Cell growth and size is considerably lower when other media type is used. 
• Optimum Seeding Density: Standard or 1x10^4 cells/mL 
• Resistant to Trypsin-EDTA; Might take up to 15 minutes to come off plastic 
without mechanical force. 
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HTB-132 (or MDA-MB-468) 
• Mammary gland adenocarcinoma cells (epithelial) 51-year-old female 
• Cells reach confluence in 3-5 days, grows very rapidly.  Cells tend to stack and bud 
off into the media, so frequent washing is recommended. 
• Media: Use Leibovitz’s L-15 Medium. 
o Complete by adding 10% FBS 
o Save ¼ of the original media, and only add 2% FBS.   
 This media is to be used for 3D assays. 
o Important: Cells grown in L-15 Media MUST be incubated in pure air.  
  Using enhanced CO2 levels will reduce viability. 
o RPMI-1640 can be used if the previous note is impossible. 
• Cytoprotectant media contains 10% FBS & 5% DMSO. 
• Optimum Seeding Density: Standard or 1x10^4 cells/mL 
 
HTB-121 (BT-483) 
• Mammary gland ducatal carcinoma cells (epithelial) 23-year-old female 
• Cells are very sensitive to pH, temperature & humidity – Take good care 
• Cell growth is patchy and slow; will probably never reach confluence. 
• Media: Use RPMI-1640 formulated with: 
o 2 mM L-glutamine 
o 10 mM HEPES 
o 1 mM sodium pyruvate 
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o 4.5 g/L glucose 
o 1.5 g/L sodium bicarbonate 
 Then, to prepare for culture supplement with: 
o 20% FBS 
o 0.01 mg/ml bovine insulin 
o Save ¼ of the original media, and only add 2% FBS.   
 This media is to be used for 3D assays. 
• Cytoprotectant media contains 20% FBS & 5% DMSO. 
• Optimum Seeding Density: High or 2.5x10^4 cells/mL 
 
3D CULTURE PROCEDURE (on-top protocol) 
1. Thaw the BME overnight at 4°C. 
a. Aliquot if many freeze-thaws are to be conducted. 
b. Keep the BME tube on ice at ALL times. 
2. Pre-chill the plate(s) or dish(es) to be used in a freezer. 
3. Make the assay media by mixing cold media with BME (EHS) to between 2 and 
10%.  Lower concentration promotes more growth & vice versa.   
a. Also, lower concentrations of FBS (2-5%) may be desirable. 
4. Follow Table 3 below for Gel Coat & Medium volumes. 
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Table 3: Recommended Gel Culture Parameters 
If the well area listed in the table is different from the wells you are using, volumes 
should be adjusted.  [68] 
Type # of Wells Diameter (mm) 
Area 
(cm2) 
Media Volume 
(µL) 
EHS coat 
(µL) 
Dish 
 
60 28.3 5,000 850 
Plates 
6 35 9.6 2,000 500 
24 16 2 500 120 
48 10 0.75 200 80 
96 6 0.26 60 15 
5. Coat the wells with the EHS coat volume and spread evenly with pipette tip. 
a. Be careful to avoid bubbles – it will dry that way. 
b. Due to the meniscus effect, there may be a bare spot in the center.  If this is 
a problem, use a little extra gel.  
6. Let the gels set for 15-20 minutes at 37°C. 
7. Prepare the cells to be plated by diluting to the Medium volume in assay medium. 
(following the table above) 
a. A good seeding density to start with is 0.2x10^5 cells/cm^2 and 0.25x10^5 
cells/cm^2 for malignant and normal cells. 
8. Pipette evenly over the gels & incubate at 37°C. 
9. Change assay media every 2 days. 
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3D EXTRACTION PROCEDURE (on-top protocol) 
This protocol is for extraction of colonies from the gels without disrupting the cells 
themselves. 
1. Make a stock solution of PBS-EDTA: 
a. 5 mM EDTA, 1 mM NaVO4, 1.5 mM NaF in PBS 
2. Prepare Ice cold PBS & PBS-EDTA 
3. Aspirate the media and rinse with ice-cold PBS 2 times. 
a. Note that all steps need to be done at 2-8°C. 
4. Add 2-3 media volumes of PBS-EDTA. 
5. Gently detach the gel by scraping with a pipette tip. 
6. Shake gently for 15-30 min. 
a. If in-well imaging is the desired endpoint you can stop here, allow the cells 
to settle to the bottom and fix. 
7. Transfer the contents to a tube, and rinse the wells with 0.5 media volume and 
transfer the rinse to the tube.  Shake the tube (on ice) for 15-30 min. 
a. If transferring colonies to slides for imaging, centrifuge at minimum speed 
for 1-2 minutes, and carefully pipette 20 µl of colonies to slide. 
b. For protein or RNA extraction, additional washing with PBS-EDTA and re-
centrifugation and re-suspension will reduce contaminating BME. 
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IMMUNOSTAINING PROCEDURE 
Reference these 2 papers: [68, 69] These steps are for 96-wells or slides. 
 
Reagents 
• PBS Glycine: 100 mM Glycine in PBS 
• IF Buffer: 0.2 % Triton,  0.1% BSA, 0.05% Tween 20 in PBS, 7.7 mM NaN3 
• IF Block: 10% Goat Serum, 1% goat F(ab’) IgG in IF Buffer 
1. Fixation method depends on the antibody.  This may include Formalin (Room 
Temp), Paraformaldehyde (RT), or 50/50 Methanol/Acetone (-20°C). 
a. I’ve had good results with 4% Paraformaldehyde for 15 minutes. 
2. Rinse with PBS-Glycine 3x for 10 minutes. 
3. Incubate in 100 µl of IF Block for 1.5 hours (use Parafilm for slides) 
4. Stain with Primary antibody in 100 µl of IF Buffer for 2 hours or overnight at 2-
8°C.  Check product info for recommended concentrations of antibody. 
5. Wash 3x for 20 min in IF Buffer. 
6. Stain with Secondary antibody in 100 µl of IF Buffer for 45 minutes. 
7. Wash for 20 min with IF Buffer. 
8. Wash 2x for 10 min in PBS. 
9. Counterstain Nuclei with DAPI or Ethidium Bromide for 5 minutes. 
10. Wash with PBS for 10 minutes. 
11. Observe and troubleshoot if needed. 
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RT PCR PROTOCOL (using SABiosciences PCR Arrays) 
RNA Extraction (using QIAGEN RNeasy kit) 
1. Sterilize all workspace and instruments by wiping down with RNase-away. 
2. Acquire cell pellet in a centrifuge tube, and remove its supernatant. 
3. Add 1 volume of Buffer RLT, and vortex the pellet. 
a. For <5x10^6 cells use 350 ul, otherwise, use 600 ul 
4. Continue vortexing continuously for 1 minute. 
5. Add 1 volume of 70% ethanol and mix well by pipetting. 
a. Remember to use ONLY RNase-free water. 
6. Transfer to an RNeasy spin column and centrifuge for 15 s at 8000 g (max speed) 
7. OPTIONAL DNase step 
a. Add 350 ul Buffer RW1 and spin for 15 s at max speed. 
b. In a separate tube, add 10 ul about 30 ku/ul DNase stock to 70 ul Buffer 
RDD 
c. Add all 80 ul to column and incubate at RT for 15 min 
d. Add 350 ul Buffer RW1 and spin at max speed. 
8. Add 700 ul Buffer RW1 and spin 15 s at max speed. 
9. Add 500 ul Buffer RPE and spin 15 s at max speed. 
10. Add 500 ul Beffer RPE and spin 2 min at max speed. 
11. Switch to new collection tube and spin for 1 min at max speed. 
12. Switch column to final collection tube for elution. 
13. Add 30-50 ul RNase-free water and spin for 1 min at max speed. 
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14. OPTIONAL: repaeat step 13 to increase yield of eluted RNA. 
15. RNA can be stored at -80 C. 
 
RNA Analysis 
1. First quantify RNA conc. By measuring A260. 
a. Remember to Blank. 
b. Use conversion of 1 = 44 ug / ml 
c. Concentration should be greater than 4 ug / ml 
2. Check Purity by measuring 260/280 ratio. 
a. 2.0-2.1 is a good ratio. (must be >2.0) 
b. Also be sure the 260/230 ratio is >1.7 
3. Prepare a Nano LabChip for use with an Agilent BioAnalyzer. 
a. Prepare 1 ul samples of 30 ng/ul RNA. 
b. 18S & 28S peaks should be sharp without shoulders or smears. 
c. Alternately, a gel could be run to do this check. 
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cDNA Synthesis 
1. Prepare DNA Elimination Mixture by adding 2 ul 5X gDNA Elimination Buffer to 
Total RNA, diluting to a total volume of 10 ul with RNase-free water. 
a. Total RNA range must be between 25 ng & 5 ug. 
b. Use same amount of RNA for each sample. 
c. The higher the amount the better for accuracy. 
2. Prepare the RT Cocktail for all samples using Table 4. 
Table 4: Reverse Transcriptase Recipe 
RT Cocktail 1 reaction 2 reactions 4 reactions 
BC3 (5X RT Buffer 3) 4 ul 8 ul 16 ul 
P2 (Primer & External Control 
Mix) 
1 ul 2 ul 4 ul 
RE3 (RT Enzyme Mix 3) 3 ul 6 ul 12 ul 
Final Volume 10 ul 20 ul 40 ul 
3. cDNA Synthesis Reaction: 
a. Add 10 ul of RT Cocktail to each 10 ul DNA Elimination Mixture & mix 
well with pipette. 
b. Incubate at 42 C for exactly 15 min and immediately stop reaction by 
heating at 95 C for 5 minutes. 
c. Add 91 ul of ddH20 to each 20 ul reaction tube, mix well. 
4. OPTIONAL: Set aside 6 ul of the cDNA template for RNA Quality Control 
Check. 
5. Store template at -20 C until use. 
  
56 
 
 
RT PCR STEP 
1. Mix the following in a separate tube to a total Volume of 2550 ul: 
a. 1275 ul 2X SABiosciences RT2 qPCR Master Mix 
b. 102 ul Diluted First Strand cDNA Syntehsis Reaction 
c. 1173 ul ddH2O 
2. Add 25 ul of Experimental cocktail to each well of the Array Plate 
3. Tightly Seal the plates with the provided 8-cap strips. 
a. Tap out any bubbles that may exist in the wells. 
b. Place on ice will setting up cycling program 
4. Use Table 5 to set up and run the program 
Table 5: RT-PCR Program 
Cycles Duration Temperature 
1 10 minutes 95 C 
40 
15 seconds 95 C 
30 – 40 seconds 55 C 
30 seconds 72 C 
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5. Use the instrument’s software to approximate the threshold cycle 
a. Use the readings from cycle 2 through 2 cycle values before the earliest 
visible amplication (between 10 and 15) to set the baseline. 
b. Use Log View of the amp. Plots and place the threshold value within the 
lower one-third to lower one-half of the linear phase. 
c. Be sure the thresholds are the same across all PCR array runs.  The value of 
CtPPC should be 18-22 across all arrays. 
d. Export the values for analysis. 
6. Run a Dissociation (Melting) Curve 
a. Use the instrument’s default, or run the following program: 
b. 95 C, 1 min; 65 C, 2 min (OPTICS OFF); 65 C to 95 C at 2 C / min 
(OPTICS ON) 
7. Visually inspect the plate for any evaporation, noting specific wells. 
8. Go to http://www.SABiosciences.com/pcrarraydataanalysis.php 
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APPENDIX B 
RAW DATA 
Table 6: Caspase Data for Malignant Cells 
Caspase Activity for BT-483 Cells 
Values are in RLUs 
Control 5 nm 24 hr 5 nm 48 hr 20 nm 24 hr 20 nm 48 hr 
Sample 7181 18080 14372 19621 24089 
7321 11994 14468 23288 24676 
Avg. 7251 15037 14420 21455 24383 
St. Dev 3200 4303 68 2593 415 
Table 7: Caspase Data for Normal Cells 
Caspase Activity for 184-B5 Cells 
Values are in RLUs 
Control 5 nm 24 hr 5 nm 48 hr 20 nm 24 hr 20 nm 48 hr 
Sample 79597 78263 75927 69469 271317 61911 66786 74365 54926 458742 
Avg. 70754 72524 75146 62197 365029 
St. Dev 12506 8115 1105 10283 132529 
Table 8: Proliferation Data for Day 3 
Values are in RFUs 
184B5 Ctrl 184B5 Rap MDA-MB-468 Ctrl MDA-MB-468 Rap Blank 
7942 6654 28022 24336 14 
7756 7396 28492 25026 -85 
8372 7746 29419 24271 71 
8023.33333 7265.333 28644.33 24544.33 avg 
315.951473 557.6032 710.849 418.3997 stdev 
  
59 
 
 
Table 9: Proliferation Data for Day 7 
Values are in RFUs 
184B5 Ctrl 184B5 Rap MDA-MB-468 Ctrl MDA-MB-468 Rap Blank 
6135 5205 31703 16569 155 
8362 5840 40376 22460 -214 
7535 5626 37569 19386 58 
7344 5557 36549.33 19471.67 avg 
1125.71888 323.0743 4425.497 2946.434 stdev 
Table 10: Cutoff RT-PCR Fold Change Values 
Gene Category Symbol Description Fold Change 
Basement Membrane Constituents COL7A1 Collagen, type VII, alpha 1 3.11 
Cell-Cell Adhesion ICAM1 Intercellular adhesion molecule 1 4.20 
Cell-Matrix Adhesion 
ITGA1 Integrin, alpha 1 1.54 
ITGA3 Integrin, alpha 3 2.80 
ITGA5 Integrin, alpha 5 1.28 
ITGB4 Integrin, beta 4 3.10 
SPP1 Secreted phosphoprotein 1 2.53 
Collagens & ECM Structural 
Constituents COL16A1 Collagen, type XVI, alpha 1 1.02 
ECM Protease Inhibitors 
TIMP1 TIMP metallopeptidase inhibitor 1 0.55 
TIMP2 TIMP metallopeptidase inhibitor 2 2.38 
ECM Proteases 
ADAMTS1 ADAM metallopeptidase 3.99 
MMP14 Matrix metallopeptidase 14 2.72 
SPG7 Spastic paraplegia 7 2.05 
Other Adhesion Molecules 
LAMB1 Laminin, beta 1 4.39 
THBS2 Thrombospondin 2 4.14 
TNC Tenascin C 2.25 
Other ECM Molecules 
CTGF Connective tissue growth factor 2.91 
ECM1 Extracellular matrix protein 1 1.48 
VTN Vitronectin 0.69 
Transmembrane Molecules PECAM1 Platelet/endothelial cell adhesion 
molecule 3.73 
 
60 
 
 
Table 11: RT-PCR Quality Control 
Quality Control Check (Ct values) 
Avg 
RTC 
Avg 
PPC 
stdev 
RTC 
stdev 
PPC 
RTC - 
PCC 
gDN
A 
Cntr. 
Plate 21.42 18.12 0.31 0.20 3.30 36.68 
Exp.Pla
te 21.95 17.96 0.19 0.19 3.99 36.20 
Table 12: Incalculable RT-PCR Data 
Gene Category Symbol Description CTL Ct TRT ct +/- 
Basement 
Membrane 
Constituents 
LAMA1 Laminin, alpha 1 N 31.3 + 
Cell-Matrix 
Adhesion 
ADAMTS8 ADAM metallopeptidase N 34.98 + 
ITGA8 Integrin, alpha 8 34.19 N - 
ITGAM Integrin, alpha M N 34.36 + 
Collagens & 
ECM Structural 
Constituents 
COL6A1 Collagen, type VI, alpha 1 N 30.88 + 
ECM Proteases 
MMP11 Matrix metallopeptidase 11 N 32.53 + 
MMP16 Matrix metallopeptidase 16 N 34.48 + 
MMP3 Matrix metallopeptidase 3 N 32.07 + 
MMP7 Matrix metallopeptidase 7 32.91 N - 
MMP9 Matrix metallopeptidase 9 N 33.03 + 
Other Adhesion 
Molecules 
CNTN1 Contactin 1 N 34.37 + 
COL15A1 Collagen, type XV, alpha 1 30.27 N - 
KAL1 Kallmann syndrome 1 sequence N 34.75 + 
Other ECM 
Molecules 
HAS1 Hyaluronan synthase 1 N 34.04 + 
THBS3 Thrombospondin 3 N 31.958 + 
Transmembrane 
Molecules 
SELL Selectin L N 33.211 + 
VCAM1 Vascular cell adhesion molecule 1 N 34.066 + 
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Table 13: Complete List of Cell Colony Areas  
Units in (µm)^2 
184-B5 BT-483 MDA-MB-468 
w/ 
EGF 
w/o 
EGF 
w/o 
RAP 
w/ 
RAP 
w/o 
RAP 
w/ 
RAP 
5119 37500 68004 3563 39203 2540 
4711 24880 44360 3472 15722 886 
4419 12171 37724 3208 11708 2324 
4393 15792 22652 2927 11243 2553 
4299 6583 21969 2798 18713 1505 
4241 6506 16455 2667 6688 1388 
4013 10215 13987 2349 4963 3070 
3618 6636 12208 2307 29354 2733 
3574 11789 11883 2188 10439 3000 
3374 13017 10643 2062 18998 1571 
3346 8903 10403 2039 26904 2596 
3137 7489 8335 2014 10612 2607 
2946 3384 11986 2004 18212 1475 
2929 15598 30362 1980 26758 2299 
2855 13828 28154 1944 27729 3737 
2765 42713 17008 1930 1071 
2593 38484 11814 1864 968 
2581 28947 6139 1790 1063 
2548 28770 7615 1738 2004 
2499 28715 1728 3074 
2386 20680 1711 2307 
2379 1664 2259 
2362 1640 2385 
2272 1579 3186 
2236 1570 1038 
2060 1523 1448 
1929 1501 1214 
1820 1404 922 
1712 1350 
1600 1340 
1543 1315 
1101 1286 
2075 1277 
3116 1165 
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4367 1155 
4231 1144 
4004 1114 
3991 1083 
3886 1041 
3626 984 
3483 959 
3304 950 
2838 938 
2803 897 
2734 812 
1894 603 
1705 3149 
1562 754 
3105 654 
2761 1008 
2748 568 
2352 817 
2080 545 
2016 1834 
1967 1087 
1714 1721 
1618 1376 
1536 
546 
513 
1051 
2400 
1120 
1983 
1290 
1362 
1490 
 
 
